Call Us Today @ 0172 - 4680800 | | NSE - BSE
India imported APIs worth Rs 18,372.54 crore in 2016-17
India imported Active Pharmaceutical Ingredients (APIs) worth Rs 18,372.54 crore in 2016-17, of which the maximum was from China, Parliament was informed today.

APIs estimated to be worth Rs 12,254.97 crore were imported from China followed by the US at Rs 820.18 crore and Italy at Rs 701.85 crore in 2016-17, the Minister of State for Health Ashwini Kumar Choubey said in the Lok Sabha.

APIs worth Rs 485.11 crore were imported from Germany while APIs Rs 422.01 was imported from Singapore.

API is the term used to refer to the biologically active component of a drug product.

In 2015-16, the country imported APIs worth Rs 21,225.97 crore with ingredients worth Rs 13,853 being imported from China, followed by Germany at Rs 1054.71 crore and the US at Rs 980.38 crore.

(Health World)
Other Related News:
FDA grants Breakthrough Therapy Designation for Roche's Hemlibra in haemophilia A without inhibitors
India plans measures to facilitate drug exports
Most Smokers With Head and Neck Cancer Have Tried to Quit
Scientists identify connection between dopamine and behavior related to pain and fear
Digital disruption in clinical trials
INS partners with WCEA to offer high-quality, infusion therapy-related education to nursing professionals around globe
Cipla arm recalls multiple lots of antidepressant drug from US
The collapse of the Venezuelan health system
Ranbaxy's demise wake-up call for business families in India
Corona Remedies acquires two brands from Abbott